Aska Pharmaceutical Holdings Co., Ltd.TSE: 4886

March 27 2023 Personnel Change of ASKA Pharmaceutical

· Issued by ASKA Pharmaceutical Holdings Co., Ltd.

Press Release

Personnel Change of ASKA Pharmaceutical

TOKYO, March 27, 2023 - ASKA Pharmaceutical Holdings Co., Ltd. (Head Office: Minato-ku, Tokyo/ President, Representative Director: Takashi Yamaguchi) announced the following personnel change of its subsidiary, ASKA Pharmaceutical Co., Ltd., effective April 1, 2023.

1. Personnel Change

Tetsuya Yamamoto

[New Responsibilities]

Director of Iwaki General Affairs Department, Production Division [Current Responsibilities]

Manager of Tokyo Sales Office, East Japan Sales Department Region 1, Sales Division

Media Contacts

ASKA Pharmaceutical Holdings Co., Ltd. Corporate Planning Department

Tel: +81-3-5484-8366

Email:kouhou@aska-pharma.co.jp